Experience

Emergent BioSolutions

• United States
• Biotechnology Research
• 700 & Above Employee

• Senior Manager, Medical Communications

  • Jun 2023 - Present



AlphaGroup - a Red Nucleus company

• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Scientific Communications Manager

  • Jun 2022 - Jun 2023

  Establish and maintain relationships with internal and external stakeholders to develop high-quality scientific content across several products/therapeutic areas. Independently construct/review content for scientific communications (abstracts, manuscripts, posters, SCP contents, lexicons, clinical trial reports) and medical affairs (MSL slide decks, FAQs, education/training materials, medical information letters) in compliance with GPP/ICMJE principles and industry… Show more Establish and maintain relationships with internal and external stakeholders to develop high-quality scientific content across several products/therapeutic areas. Independently construct/review content for scientific communications (abstracts, manuscripts, posters, SCP contents, lexicons, clinical trial reports) and medical affairs (MSL slide decks, FAQs, education/training materials, medical information letters) in compliance with GPP/ICMJE principles and industry regulations. Interface with biotech/pharmaceutical clients, physicians, and thought leaders to collect key insights for project-level and product-level medical/publication strategy, including journal selection and congress planning, from various stages of clinical development through launch and lifecycle management. Provide client support with annotation and publication management systems (eg, Veeva, DataVision, PubStrat, etc.) and other software. Manage multiple projects under fast-paced timelines while proactively communicating with cross-functional partners to ensure alignment. Identify/implement process improvements to increase efficiency (in-house training materials) and automation (high-frequency literature monitoring and strategic gap analyses automation) within department. Remain current on disease state and market landscape to produce accurate, relevant, high-quality materials for congress/journal submission and field medical use. Show less



Cornell University

• United States
• Higher Education
• 700 & Above Employee

• Ph.D. Candidate in Biomedical Engineering

  • Aug 2017 - May 2022

  Ithaca, New York Area Developing devices and techniques for global point-of-care diagnosis of infectious disease and cancer • Contributing author on 8 peer-reviewed publications – 3 as first-author. Presented research at 3 conferences, 2 departmental seminars, a clinical immersion seminar, and monthly update meetings with collaborators. • Pioneered a novel DNA-based approach for cancer diagnosis in sub-Saharan Africa, developing devices and techniques to achieve diagnosis at the point-of-care. On a trial of… Show more Developing devices and techniques for global point-of-care diagnosis of infectious disease and cancer • Contributing author on 8 peer-reviewed publications – 3 as first-author. Presented research at 3 conferences, 2 departmental seminars, a clinical immersion seminar, and monthly update meetings with collaborators. • Pioneered a novel DNA-based approach for cancer diagnosis in sub-Saharan Africa, developing devices and techniques to achieve diagnosis at the point-of-care. On a trial of 506 Ugandan patients, we achieved 96% accuracy in ~2 hours compared to 77% current accuracy of Kaposi’s sarcoma diagnosis (which takes 3-6 weeks). • Designed and implemented training materials and digital resources for domestic and global collaborators regarding disease state, device operation, and molecular techniques. Served as lead scientific/engineering expert on international cross-functional team of 16 dermatologists, engineers, pathologists, and epidemiologists, enabling expansion to 10 sites in 6 countries across Africa. • Led engineering efforts in industrial partnership with FoxConn through the NIH Rapid Acceleration of Diagnostics (RADx) program for strategic development and commercialization of a COVID-19 diagnostic device.

• Graduate Teaching Assistant

  • Aug 2019 - Dec 2019

  • Organized and lead bi-weekly office hours and review sessions for 75 students • Created testing materials for three exams and maintained class website and records



Weill Cornell Medicine

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Clinical Immersion Fellow

  • Jun 2018 - Aug 2018

  Greater New York City Area Advisor: Roger Hartl, M.D. – Brain and Spine Center • Performed investigational research on treatment of intervertebral disc herniation, resulting in publication in Science Translational Medicine. • Initiated a second publication regarding retrospective analysis on the incidence of adjacent disc disease following spinal fusion. • Attended clinical rounds, research meetings, patient consultations, and surgeries Advisor: Ana Krieger, M.D. – Center for Sleep Medicine • Attended… Show more Advisor: Roger Hartl, M.D. – Brain and Spine Center • Performed investigational research on treatment of intervertebral disc herniation, resulting in publication in Science Translational Medicine. • Initiated a second publication regarding retrospective analysis on the incidence of adjacent disc disease following spinal fusion. • Attended clinical rounds, research meetings, patient consultations, and surgeries Advisor: Ana Krieger, M.D. – Center for Sleep Medicine • Attended patient consultations and research meetings to gain additional clinical perspective. Show less



University at Albany, SUNY

• United States
• Higher Education
• 700 & Above Employee

• Undergraduate Research Assistant

  • Sep 2016 - May 2017

  CNSE - Laboratory of Nathaniel Cady Advisor: Nathaniel Cady, Ph.D. • Initiated development of a DNA-hybridization biosensor for identifying high-risk strains of B. burgdorferi (Lyme disease) infection.



Cold Spring Harbor Laboratory

• United States
• Research Services
• 700 & Above Employee

• Scientific Intern

  • Jun 2015 - Aug 2015

  Tuveson Laboratory Advisor: David Tuveson, M.D. Ph.D. • Investigated imaging approach to assess efficacy of novel therapeutics for pancreatic cancer.